MDRNA inks new research pact with Pfizer; The therapeutic benefits of dark chocolate;

 @FierceBiotech: Two high-profile biotech CEOs assess impact of reform bill. Report | Follow @FierceBiotech

 @JohnCFierce: According to Repros' last quarterly report, it ended 09 with $1.9M in cash and its third annual going concern warning. | Follow @JohnCFierce

> MDRNA announced a new RNAi research collaboration with Pfizer, its fourth pact in the past nine months. Financial terms were not released. MDRNA release

> The lab supplier Life Technologies is pledging to expand its operation in Frederick, MD, adding 100 jobs. Story

> The Durham, NC-based drug development services company Patheon is raising $280 million in a private placement. Report

And Finally... Chocolate may be good for you--at least in small quantities and preferably if it's dark chocolate--according to research that shows just one small square of chocolate a day can lower your blood pressure and reduce your risk of heart disease. The study is published online on March 31 in the European Heart Journal. Release

Suggested Articles

Insitro picked up $143 million to build out its technology, pursue new targets and advance treatments for genetically defined patient groups.

Generation Bio filed for a $215 million IPO to advance a pair of gene therapies for liver disease and push one of them into the clinic.

The IPO will push Avidity's lead muscle disorder program through IND-enabling studies and into the clinic in 2021.